Celiac Disease Therapeutic and Drug Pipeline Review H2



Wise.Guy.

Celiac Disease Pharmaceutical and Healthcare Pipeline Review H2

PUNE, INDIA, December 6, 2016 /EINPresswire.com/ — Get Sample Report @ https://www.wiseguyreports.com/sample-request/362878-celiac-disease-global-clinical-trials-review-h1-2016

Summary
Celiac Disease Global Clinical Trials Review, H1, 2016" provides an overview of Celiac Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Celiac Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope
– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

Reasons to buy
– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Countries Contributing to Clinical Trials in Asia-Pacific 8
Top Five Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in North America 10
Top Countries Contributing to Clinical Trials in Middle East and Africa 11
Top Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Celiac Disease to Gastrointestinal Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Celiac Disease to Gastrointestinal Clinical Trials 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Sponsors 23
Top Companies Participating in Celiac Disease Therapeutics Clinical Trials 24
Prominent Drugs 25
Clinical Trial Profile Snapshots 26
Appendix 56
Abbreviations 56
Definitions 56
…Continued

Access Report @ https://www.wiseguyreports.com/reports/362878-celiac-disease-global-clinical-trials-review-h1-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Anal Fissure Pharmaceutical and Healthcare Pipeline Review H2



Wise.Guy.

Anal Fissure Therapeutic and Drug Pipeline Review H2

PUNE, INDIA, December 6, 2016 /EINPresswire.com/ — Anal Fissure Global Clinical Trials Review, H1, 2016

Get Sample Report @ https://www.wiseguyreports.com/sample-request/362875-anal-fissure-global-clinical-trials-review-h1-2016

Summary
“Anal Fissure Global Clinical Trials Review, H1, 2016" provides an overview of Anal Fissure clinical trials scenario. This report provides top line data relating to the clinical trials on Anal Fissure. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope
– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

Reasons to buy
– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Countries Contributing to Clinical Trials in Asia-Pacific 8
Top Five Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in North America 10
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 11
Clinical Trials by G7 Countries: Proportion of Anal Fissure to Gastrointestinal Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Anal Fissure to Gastrointestinal Clinical Trials 15
Clinical Trials by Phase in E7 Countries 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Sponsors 23
Top Companies Participating in Anal Fissure Therapeutics Clinical Trials 24
Prominent Drugs 25
Clinical Trial Profile Snapshots 26
Appendix 53
Abbreviations 53
Definitions 53
Research Methodology 54
Secondary Research 54
…Continued

Access Report @ https://www.wiseguyreports.com/reports/362875-anal-fissure-global-clinical-trials-review-h1-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

United States, EU, Japan, China, India and Southeast Asia Biosimulation Market 2016 Analysis and Forecast to 2021

This report studies the Global Biosimulation Market, analyzes and researches the Biosimulationforecast in United States, EU, Japan, India and Southeast Asia.

PUNE, INDIA , December 6, 2016 /EINPresswire.com/ — United States, EU, Japan, China, India and Southeast Asia Biosimulation Market

Get Sample Report@ https://www.wiseguyreports.com/sample-request/795720-united-states-eu-japan-and-forecast-2021

This report studies the Global Biosimulation Market, analyzes and researches the Biosimulation development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Certara
Simulation Plus
Dassault Systèmes
Schr?dinger
Advanced Chemistry Development
Chemical Computing Group
Entelos
Genedata Ag
Physiomics PLC
Rhenovia Pharma

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Application, Biosimulation can be split into
Application 1
Application 2
Application 3

Complete Report Details@ https://www.wiseguyreports.com/reports/795720-united-states-eu-japan-and-forecast-2021

Table of Contents

United States, EU, Japan, China, India and Southeast Asia Biosimulation Market Size, Status and Forecast 2021
1 Industry Overview of Biosimulation
1.1 Biosimulation Market Overview
1.1.1 Biosimulation Product Scope
1.1.2 Market Status and Outlook
1.2 Global Biosimulation Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Biosimulation Market by End Users/Application
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3

2 Global Biosimulation Competition Analysis by Players
2.1 Biosimulation Market Size (Value) by Players (2015-2016)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Certara
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Biosimulation Revenue (Value) (2011-2016)
3.1.5 Recent Developments
3.2 Simulation Plus
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Biosimulation Revenue (Value) (2011-2016)
3.2.5 Recent Developments
3.3 Dassault Systèmes
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Biosimulation Revenue (Value) (2011-2016)
3.3.5 Recent Developments
3.4 Schr?dinger
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Biosimulation Revenue (Value) (2011-2016)
3.4.5 Recent Developments
3.5 Advanced Chemistry Development
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Biosimulation Revenue (Value) (2011-2016)
3.5.5 Recent Developments
3.6 Chemical Computing Group
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Biosimulation Revenue (Value) (2011-2016)
3.6.5 Recent Developments
3.7 Entelos
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Biosimulation Revenue (Value) (2011-2016)
3.7.5 Recent Developments
3.8 Genedata Ag
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Biosimulation Revenue (Value) (2011-2016)
3.8.5 Recent Developments
3.9 Physiomics PLC
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Biosimulation Revenue (Value) (2011-2016)
3.9.5 Recent Developments
3.10 Rhenovia Pharma
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Biosimulation Revenue (Value) (2011-2016)
3.10.5 Recent Developments

Continued…

Purchase Report@ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=795720

For more information or any query mail at sales@wiseguyreports.com

Contact Us:
Norah Trent
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

OProCyn® OPC 3 Month Supplement Product Launched at ISOTONIC-OPC.NET

Advanced Functional Nutrition Inc. launches OProCyn brand antioxidant dietary supplement product for affordability and the best quality.

SAN DIEGO, CALIFORNIA, UNITED STATES, December 6, 2016 /EINPresswire.com/ — OProCyn® OPC 3 Month Supplement Product Launched at ISOTONIC-OPC.NET By Christine Steward 10/20/2016, San Diego California: Advanced Functional Nutrition Inc. (AFNSD) launches OProCyn brand antioxidant dietary supplement product at www.isotonic-opc.net. OPC, a 3-letter acronym for Oligomeric Proanthocyanidin Complex, is commonly known as super antioxidant, 20 times stronger than Vitamin C and 50 times stronger than Vitamin E. An OPC supplement in isotonic form has been proven to be the most effective for absorption in the human body, and to be the most popular for consumers in USA. An isotonic OPC product is normally derived from a combination of 3 natural product extracts: pine bark, grape seed and red wine.

OPCs are the most potent antioxidants found in the nature, and help to prevent / relieve oxidative stress that causes inflammation and accelerates aging of the human body. Acting as antioxidants, OPCs promote skin health, and are beneficial to people of a variety of conditions such as arthritis, obesity, cardiovascular disease, type 2 diabetes, age-related macular degeneration (AMD) and Alzheimer’s disease (AD). *Help enhance human immune system; *Support cardiovascular and blood vessel function; *Help balance cholesterol level; *Help maintain healthy blood glucose levels; *Help protecting collagen and enhance and improving skin elasticity and smoothness; * Demonstrated anti-inflammatory properties for arthritis.

OPCs extracted from grape seed and pine bark are the most researched natural health ingredients in the scientific literature and 300 papers are published each year for the last 10 years. OPCs have been scientifically demonstrated to have a wide range of roles regulating the functional enzymes that are critical for the well-being of human life, in addition to the powerful roles as antioxidants. OProCyn brand product is made of the best OPC 3 ingredients imported from France, including French maritime pine bark extract, French grape seed extract and French red wine extract. OProCyn is a brand to address the issues of the both quality and affordability for ordinary consumers to pursue healthier life. AFNSD is a San Diego based company and an independent distributor of top quality and economical health products, with exclusive legal right in selling and distributing OProCyn brand products. AFNSD strives to beat any competition and will keep OProCyn as the most competitive brand in the global market.

Christine Steward is Senior Vice President at AFNSD: Phone: 877-245-6006; Email: opc@oprocyn.biz; Website: http://www.isotonic-opc.net

Christine Steward
Advanced Functional Nutrition Inc. San Diego
877-245-6006
email us here


Source: EIN Presswire

CAD/CAM Dental Systems 2016 Global Market Size,Status and Forecast to 2021

WiseGuyReports.Com Publish a New Market Research Report On – “CAD/CAM Dental Systems 2016 Global Market Size,Status and Forecast to 2021”.

PUNE, INDIA, December 5, 2016 /EINPresswire.com/ —

This report studies CAD/CAM Dental Systems in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Sirona
3M
Kavo
Nobel Biocare
Straumann
PLANMECA
Roland
Worknc
Imes-icore
Dentsply

Get Sample Report @ https://www.wiseguyreports.com/sample-request/795261-global-cad-cam-dental-systems-market-research-report-2016

For more information or any query mail at sales@wiseguyreports.com

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of CAD/CAM Dental Systems in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III

Split by application, this report focuses on consumption, market share and growth rate of CAD/CAM Dental Systems in each application, can be divided into
Application 1
Application 2
Application 3

Complete Report Details @ https://www.wiseguyreports.com/reports/795261-global-cad-cam-dental-systems-market-research-report-2016

Table Of Contents – Major Key Points

Global CAD/CAM Dental Systems Market Research Report 2016
1 CAD/CAM Dental Systems Market Overview
1.1 Product Overview and Scope of CAD/CAM Dental Systems
1.2 CAD/CAM Dental Systems Segment by Type
1.2.1 Global Production Market Share of CAD/CAM Dental Systems by Type in 2015
1.2.2 Type I
1.2.3 Type II
1.2.4 Type III
1.3 CAD/CAM Dental Systems Segment by Application
1.3.1 CAD/CAM Dental Systems Consumption Market Share by Application in 2015
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 CAD/CAM Dental Systems Market by Region
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 China Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of CAD/CAM Dental Systems (2011-2021)

2 Global CAD/CAM Dental Systems Market Competition by Manufacturers
2.1 Global CAD/CAM Dental Systems Production and Share by Manufacturers (2015 and 2016)
2.2 Global CAD/CAM Dental Systems Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global CAD/CAM Dental Systems Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers CAD/CAM Dental Systems Manufacturing Base Distribution, Sales Area and Product Type
2.5 CAD/CAM Dental Systems Market Competitive Situation and Trends
2.5.1 CAD/CAM Dental Systems Market Concentration Rate
2.5.2 CAD/CAM Dental Systems Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

……..

7 Global CAD/CAM Dental Systems Manufacturers Profiles/Analysis
7.1 Sirona
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 CAD/CAM Dental Systems Product Type, Application and Specification
7.1.2.1 Type I
7.1.2.2 Type II
7.1.3 Sirona CAD/CAM Dental Systems Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 3M
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 CAD/CAM Dental Systems Product Type, Application and Specification
7.2.2.1 Type I
7.2.2.2 Type II
7.2.3 3M CAD/CAM Dental Systems Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 Kavo
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 CAD/CAM Dental Systems Product Type, Application and Specification
7.3.2.1 Type I
7.3.2.2 Type II
7.3.3 Kavo CAD/CAM Dental Systems Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 Nobel Biocare
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 CAD/CAM Dental Systems Product Type, Application and Specification
7.4.2.1 Type I
7.4.2.2 Type II
7.4.3 Nobel Biocare CAD/CAM Dental Systems Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
7.5 Straumann
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
7.5.2 CAD/CAM Dental Systems Product Type, Application and Specification
7.5.2.1 Type I
7.5.2.2 Type II
7.5.3 Straumann CAD/CAM Dental Systems Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5.4 Main Business/Business Overview
7.6 PLANMECA
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
7.6.2 CAD/CAM Dental Systems Product Type, Application and Specification
7.6.2.1 Type I
7.6.2.2 Type II
7.6.3 PLANMECA CAD/CAM Dental Systems Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview
7.7 Roland
7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
7.7.2 CAD/CAM Dental Systems Product Type, Application and Specification
7.7.2.1 Type I
7.7.2.2 Type II
7.7.3 Roland CAD/CAM Dental Systems Production, Revenue, Price and Gross Margin (2015 and 2016)
7.7.4 Main Business/Business Overview
7.8 Worknc
7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
7.8.2 CAD/CAM Dental Systems Product Type, Application and Specification
7.8.2.1 Type I
7.8.2.2 Type II
7.8.3 Worknc CAD/CAM Dental Systems Production, Revenue, Price and Gross Margin (2015 and 2016)
7.8.4 Main Business/Business Overview
7.9 Imes-icore
7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
7.9.2 CAD/CAM Dental Systems Product Type, Application and Specification
7.9.2.1 Type I
7.9.2.2 Type II
7.9.3 Imes-icore CAD/CAM Dental Systems Production, Revenue, Price and Gross Margin (2015 and 2016)
7.9.4 Main Business/Business Overview
7.10 Dentsply
7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
7.10.2 CAD/CAM Dental Systems Product Type, Application and Specification
7.10.2.1 Type I
7.10.2.2 Type II
7.10.3 Dentsply CAD/CAM Dental Systems Production, Revenue, Price and Gross Margin (2015 and 2016)
7.10.4 Main Business/Business Overview

……..CONTINUED

For more information or any query mail at sales@wiseguyreports.com

Buy 1-User PDF @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=795261

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Healthcare IOT Security Market Global Key Players, Share, Trend, Applications, Segmentation and Forecast to 2022

The global healthcare IOT security market is expected to reach $ 48.18 billion by 2022 at a CAGR of 39.44% during the forecast period.

PUNE, INDIA, December 5, 2016 /EINPresswire.com/ — Healthcare IOT Security Market:

Report Description

In the process of enhancing healthcare outcomes of patients and minimize costs, healthcare providers have suffered from several troublesome problems, especially in terms of the infrequent interactions with their patients, giving them negligible understanding of the patient’s activities which impact their overall health. Healthcare providers can make effective decisions if there is an automatic flow of information between patients and care givers which helps in the better analysis of the health information. Internet of Things (IOT) is making this possible in the healthcare sector.

• The global healthcare IOT security market is expected to reach $ 48.18 billion by 2022 at a CAGR of 39.44% during the forecast period.
• On the basis of IOT Security solutions, Endpoint Security is by far the fastest growing segment of global healthcare IOT security market and it is expected to reach $5.93 billion by 2022. .
• Based on IOT Security services, risk assessment services commands largest market share of global healthcare IOT security market and it is expected to grow at a CAGR of 39.69% during the period 2016 to 2022.

Request Sample Report @ https://www.wiseguyreports.com/sample-request/796556-global-healthcare-iot-security-market-estimation-forecast-2016-2022

Globally, since the usage of mHealth applications and wearable is continuously increasing, IOT Security will play a crucial role in the protection of the big data (health information) collected and communicated from various smart devices to the care givers and patients.

North America is the region acquiring a major share in the healthcare IOT adoption; therefore, data security of the protected health information becomes pivotal. 53% physicians in Europe are concerned about security and privacy issues related to mHealth applications. APAC is becoming the global hub for clinical trials and comprises of 60% of the world population, moreover, healthcare IOT adoption is rapidly increasing and therefore, IOT security becomes crucial. 42% of the firms in Latin America are concerned about healthcare IOT Security threats.

North America is the region acquiring a major share 47.93% in the healthcare IOT Security because of the rapid adoption of healthcare IOT. APAC is expected to grow at a highest CAGR 46.24% as this region comprises 60% of the world population and with the raid healthcare IOT adoption for managing growing chronic illness, IOT security will become crucial in the near future.

Key Players
The leading market players in the global healthcare IOT security market include; IBM Corporation (U.S.), Cisco Systems Inc. (U.S.), Intel Corporation (U.S.), Oracle Corporation (U.S.), Sophos Group Plc. (U.K.), Symantec Corporation (U.S.), Trend Micro Inc. (Japan), Kaspersky Labs (Russian Federation) and others.  

Access Report @ https://www.wiseguyreports.com/reports/796556-global-healthcare-iot-security-market-estimation-forecast-2016-2022

Study Objectives of Healthcare IOT security Market Development and Demand Forecast to 2022 Market
Ø To provide insights about factors, influencing and affecting the market growth.
Ø To provide historical and forecast revenue of the market segments and sub-segments with respect to regional markets and their countries.
Ø To provide historical and forecast revenue of the market segments based on type of test, and type of sample for global healthcare IOT security market.
Ø To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market.
Ø To provide economic factors that influences the global healthcare IOT security market.

Target Audience
• M-health solutions & services providers
• Forensic laboratories
• Research Laboratories
• Hospitals & Clinics
• Service Suppliers
• Potential Investors
• Key executive (CEO and COO) and strategy growth manager

Key Findings
• The global market for healthcare IOT security is expected to grow at a CAGR of 39.44% during the period 2016 to 2022 to reach $48.18 billion by 2022.
• The Asian healthcare IOT security market is expected to grow rapidly during 2016 to 2022; whereas, North America will remain the largest market by 2022.
• By IOT security solutions, Endpoint Security segment is expected to witness highest CAGR of 40.52% during the period 2016 to 2022.
• Based on the IOT security services, risk assessment services segment commands the largest market share of global healthcare IOT security market; registered 27.5% share in 2015
• IBM Corporation (U.S.), Cisco Systems Inc. (U.S.), Intel Corporation (U.S.), Oracle Corporation (U.S.) are so far the leading market players for healthcare IOT security market globally

Regional and Country Analysis of Healthcare IOT security Market Development and Demand Forecast to 2022 Market

As per the MRFR analysis, the Asia healthcare IOT security market is poised to reach $10.81 billion by 2022, to grow at a CAGR of around XX% during the forecasted period. European market was valued at $ 1.40 billion in 2015, and expected to reach at $ 13.71 billion by 2022. North America continues to be the leading region during the forecast period.
The reports also cover country level analysis:
• North America
o US
o Canada
• Europe
o Germany
o U.K.
o Italy
o Spain
o France
o Rest of Western Europe
o Eastern Europe
• Asia-Pacific
o Japan
o China
o India
o Republic of Korea
o Rest of Asia-Pacific

…CONTINUED

Buy this Report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=796556

NORAH TRENT
Wise Guy Reports
+91 841 198 5042
email us here


Source: EIN Presswire

Global Healthcare Supply Chain Market 2016 Share, Trend, Segmentation and Forecast to 2021

focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions,

PUNE, MAHARASHTRA, INDIA, December 5, 2016 /EINPresswire.com/ — Healthcare Supply Chain Industry

Description

Wiseguyreports.Com Adds “Healthcare Supply Chain -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021” To Its Research Database

This report studies sales (consumption) of Healthcare Supply Chain in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

Bayer
Pfizer
Merck Corporation
BASF
Bachem
Johnson & Johnson
Decartis
Roche
Sanofi-Aventis
GSK
Astrazeneca
Eli Lilly
AMPAC Fine Chemicals

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/795792-global-healthcare-supply-chain-sales-market-report-2016

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Healthcare Supply Chain in these regions, from 2011 to 2021 (forecast), like
United States
China
Europe
Japan

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Type I
Type II
Type III

Split by applications, this report focuses on sales, market share and growth rate of Healthcare Supply Chain in each application, can be divided into
Application 1
Application 2
Application 3

Leave a Query @ https://www.wiseguyreports.com/enquiry/795792-global-healthcare-supply-chain-sales-market-report-2016

Table of Contents

Global Healthcare Supply Chain Sales Market Report 2016
1 Healthcare Supply Chain Overview
1.1 Product Overview and Scope of Healthcare Supply Chain
1.2 Classification of Healthcare Supply Chain
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Healthcare Supply Chain
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Healthcare Supply Chain Market by Regions
1.4.1 United States Status and Prospect (2011-2021)
1.4.2 China Status and Prospect (2011-2021)
1.4.3 Europe Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Healthcare Supply Chain (2011-2021)
1.5.1 Global Healthcare Supply Chain Sales and Growth Rate (2011-2021)
1.5.2 Global Healthcare Supply Chain Revenue and Growth Rate (2011-2021)

7 Global Healthcare Supply Chain Manufacturers Analysis
7.1 Bayer
7.1.1 Company Basic Information, Manufacturing Base and Competitors
7.1.2 Healthcare Supply Chain Product Type, Application and Specification
7.1.2.1 Type I
7.1.2.2 Type II
7.1.3 Bayer Healthcare Supply Chain Sales, Revenue, Price and Gross Margin (2011-2016)
7.1.4 Main Business/Business Overview
7.2 Pfizer
7.2.1 Company Basic Information, Manufacturing Base and Competitors
7.2.2 119 Product Type, Application and Specification
7.2.2.1 Type I
7.2.2.2 Type II
7.2.3 Pfizer Healthcare Supply Chain Sales, Revenue, Price and Gross Margin (2011-2016)
7.2.4 Main Business/Business Overview
7.3 Merck Corporation
7.3.1 Company Basic Information, Manufacturing Base and Competitors
7.3.2 130 Product Type, Application and Specification
7.3.2.1 Type I
7.3.2.2 Type II
7.3.3 Merck Corporation Healthcare Supply Chain Sales, Revenue, Price and Gross Margin (2011-2016)
7.3.4 Main Business/Business Overview
7.4 BASF
7.4.1 Company Basic Information, Manufacturing Base and Competitors
7.4.2 Dec Product Type, Application and Specification
7.4.2.1 Type I
7.4.2.2 Type II
7.4.3 BASF Healthcare Supply Chain Sales, Revenue, Price and Gross Margin (2011-2016)
7.4.4 Main Business/Business Overview
7.5 Bachem
7.5.1 Company Basic Information, Manufacturing Base and Competitors
7.5.2 Product Type, Application and Specification
7.5.2.1 Type I
7.5.2.2 Type II
7.5.3 Bachem Healthcare Supply Chain Sales, Revenue, Price and Gross Margin (2011-2016)
7.5.4 Main Business/Business Overview
7.6 Johnson & Johnson
7.6.1 Company Basic Information, Manufacturing Base and Competitors
7.6.2 Million USD Product Type, Application and Specification
7.6.2.1 Type I
7.6.2.2 Type II
7.6.3 Johnson & Johnson Healthcare Supply Chain Sales, Revenue, Price and Gross Margin (2011-2016)
7.6.4 Main Business/Business Overview
7.7 Decartis
7.7.1 Company Basic Information, Manufacturing Base and Competitors
7.7.2 Pharma & Healthcare Product Type, Application and Specification
7.7.2.1 Type I
7.7.2.2 Type II
7.7.3 Decartis Healthcare Supply Chain Sales, Revenue, Price and Gross Margin (2011-2016)
7.7.4 Main Business/Business Overview
7.8 Roche
7.8.1 Company Basic Information, Manufacturing Base and Competitors
7.8.2 Product Type, Application and Specification
7.8.2.1 Type I
7.8.2.2 Type II
7.8.3 Roche Healthcare Supply Chain Sales, Revenue, Price and Gross Margin (2011-2016)
7.8.4 Main Business/Business Overview
7.9 Sanofi-Aventis
7.9.1 Company Basic Information, Manufacturing Base and Competitors
7.9.2 Product Type, Application and Specification
7.9.2.1 Type I
7.9.2.2 Type II
7.9.3 Sanofi-Aventis Healthcare Supply Chain Sales, Revenue, Price and Gross Margin (2011-2016)
7.9.4 Main Business/Business Overview
7.10 GSK
7.10.1 Company Basic Information, Manufacturing Base and Competitors
7.10.2 Product Type, Application and Specification
7.10.2.1 Type I
7.10.2.2 Type II
7.10.3 GSK Healthcare Supply Chain Sales, Revenue, Price and Gross Margin (2011-2016)
7.10.4 Main Business/Business Overview
7.11 Astrazeneca
7.12 Eli Lilly
7.13 AMPAC Fine Chemicals

Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=795792

Continued…

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (US) Ph: +44 208 133 9349 (UK)

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Global Urology Devices Market Dialysis, Urinary Stone, chronic kidney diseases, urinary incontinence- Forecast to 2027



MRFR6.png

Global Urology Devices Market Information by Device type (Dialysis Equipment, Urinary Stone Treatment devices, others), by application – Forecast to 2027

Key Players : American Medical Systems (U.S.), Boston Scientific (U.K.), Olympus (U.S.), Coloplast (Denmark), and Cook Medical (U.S.) C.R. Bard (U.S.), Endo Health Solutions Inc. (U.S)

— Market Research Future

PUNE, MAHARASTRA, INDIA, December 5, 2016 /EINPresswire.com/ — Market Highlights

Globally the market for Urology Devices is increasing rapidly. The factors that influence the growth of Urology Devices Market; increasing growth in advance healthcare devices , patients with kidney diseases and find diseases faster and accurate and many others.
Asia-Pacific represents the largest market worldwide for Urology Devices especially in U.S., U.K, China, Indonesia, Vietnam and India.

Segmentation

The market for Urology Devices Market is segmented into mainly two; by types and by application and its various sub-segments. By types include Dialysis Equipment, Urinary Stone Treatment devices, Endoscopy Devices, Benign Prostatic Hyperplasia Treatment Devices and others. Whereas by treatment it includes chronic kidney diseases, urinary incontinence and others

“Ask for your specific company profile and country level customization on report.”
Request a Sample Copy @ https://www.marketresearchfuture.com/sample-request/global-urology-devices-market-research-report-forecast-to-2027

The Key Players of Global urology Devices Market

• American Medical Systems (U.S.)
• Boston Scientific (U.K.)
• Olympus (U.S.)
• Coloplast (Denmark)
• Cook Medical (U.S.)
• C.R. Bard (U.S.)
• Endo Health Solutions Inc. (U.S)

Study Objectives of Urology Devices

• To provide detailed analysis of the market structure along with forecast for the next 10 years of the various segments and sub-segments of the global Urology Devices market
• To provide insights about factors affecting the market growth
• To Analyze the Urology Devices market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
• To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia, and Rest of the World (ROW)
• To provide country level analysis of the market with respect to the current market size and future prospective
• To provide country level analysis of the market for segment by Device type, by application and its sub-
segments.

Taste the market data and market information presented through more than 60 market data tables and figures spread over 100 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Global Urology Devices Market Research Report – Forecast to 2027”.

Brief TOC of Urology Devices Market

1 Executive Summary
2 Market Introductions
2.1 Definition
2.2 Scope of the study
2.2.1 Research Objectives
2.2.2 Assumptions
3 Research methodologies
3.1 Research process
3.2 Secondary research
3.3 Primary research
4 MARKET DYNAMICS
4.1 Drivers
4.2 Restraints
5 MARKET TRENDS
5.1 Trends in Supply/Production
5.2 Trends in Demand/Consumption
5.3 Emerging Markets (Supply & Demand)
5.4 Emerging Brands
6 MARKET FACTOR ANALYSES
6.1 Introduction
Continued……

Browse full TOC, Tables, Figures and Companies mentioned @ https://www.marketresearchfuture.com/reports/global-urology-devices-market-research-report-forecast-to-2027

Regional Analysis of Urology Devices Market
North America dominated the Global Urology Devices market with the largest market share, accounting for $XX million and is expected to grow over $XX billion by 2027. The European market for Urology Devices is expected to grow at XX% GAGR (2016-2027). Asia-Pacific is expected to grow at CAGR of XX% from $ XX million in 2016 to $XX million by 2027.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
Akash Anand
Market Research Future
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com

Akash Anand
Market Research Future
+1 646 845 9312
email us here


Source: EIN Presswire

Research Article on US and Europe Connected Health Devices: Market Dynamics,Major Companies Analysis and Forecast- 2023



Market Research Future

US and Europe Connected Health Devices market information & Analysis (Market Data, Major Player) and Forecast to 2023

For the purpose of this study, market research future has segmented the digital healthcare market by digital healthcare types, digital healthcare devices, and its applications.

— Market Research Future

PUNE, MAHARASHTRA, INDIA, December 5, 2016 /EINPresswire.com/ — Introduction to Connected Health Device

Connected health device are tools of digital technology to provide access and to share information as well as data across healthcare system. These healthcare systems are nothing but are the hospitals, clinics, medical stores etc. As per the current market trends people are trying to raise their living standard. Due to this, they are unable to dedicate the required attention towards their personal health. Hence there is a significant increase for the health related minor and major issues. Connected health devices help to connect patient and doctors remotely. Connected healthcare devices are also known by terms like telecare, telehealth, telemedicine, mhealth, digital health and e-health. These devices are available in various forms and sizes according as per the customer’s requirement. However, such devices there has long way to establish in the market as companies have to build strong brand image in the market.

"UK, with more than 100,000 health apps, rapid growth in wearable and 70 % of the UK population who now owes a smartphone and increase in use of digital technology will revolutionize the future of health and social care.”

Request a Sample Copy of this Research Article @ https://www.marketresearchfuture.com/ask-sample-request/us-europe-connected-health-devices-market-information-analysis-market-data-major-player-forecast-2023

Major Players:

The prominent market players exist in global connected healthcare market are: A&D Medical, Aerotel, Animas Corporation, BL Healthcare, Body Media Inc., Boston Scientific, DexCom Inc., Docobo, eHIT Ltd, eDevice, FitSense Technology, iMetrikus, Instromedix (Card Guard), Masimo Corporation, Medtronic, Microlife, Nellcor, Nonin Medical, Omron, PHD Medical, Philips, St. Jude Medical, Tunstall, ViTelNet, and WebVMC.

Market Segmentation:

For the purpose of this study, market research future has segmented the digital healthcare market by digital healthcare types, digital healthcare devices, and its applications. Digital healthcare are categorized into four subgroups mainly: Telehealth, Telecare, wellness/Fitness and e-health which have their own subgroups. Digital Healthcare devices are like dental examination cameras, Digital ECG and Holters, Quell Relief, pedometer fitness apps, online healthcare insurance, wearable band and many more.

More Details about Article @ https://www.marketresearchfuture.com/articles/us-europe-connected-health-devices-market-information-analysis-market-data-major-player-forecast-2023

Market Growth Influencer:

The Global e-Healthcare market growth is growing with the rapid growth rate. This high growth is due to the increasing usage of smartphones is increasing. With the increased usage of digital technology, number of health apps on IOS and Android has more than doubled in 2.5 years to mover 1,00,000 Furthermore, this growth rate is also enhance by the ability of providing the quick service is required by consumers to save theirs time from his busy schedule.

In this study, market research future has found that more than 25% of users having health issues would first try a device with usability to track their health condition and progress. Also, 27 percent of mobile phone users would prefer a personalized plan to help guide them through their journey to better health.
Increasing disposable incomes, growing of usage of technology and growing rate of production of technical equipment like Asthma management kit, Valedo Management kit, Health patch MD Smart medical devices, Digital Pill, Google’s Smart Contact lenses, and Qardiocore (Connected ECG monitor) will drive the growth in medical field in future.

Regional analysis:

Significant mhealth market growth predicted global revenue to be 50-55% per year. In 2013 the mHealth value recorded was $2.4 billion and thus forecasted that this will reach to approximate $21.5 billion after 2018. In European market also the predicted highest annual growth rate is 50-60%.

The factors which will drive the increase in use of health apps would be easy to use, simple in design and give guarantee of data security.

Ask for Table of Contents of this Report @ https://www.marketresearchfuture.com/ask-toc-request/us-europe-connected-health-devices-market-information-analysis-market-data-major-player-forecast-2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Akash Anand
Market Research Future
+1 646 845 9312
email us here


Source: EIN Presswire

Continual Compliance Solutions Launches Revolutionary HIPAA Management Software for Independent Healthcare Practices

Abyde™ is a user-friendly tool that eliminates the burden of keeping up with HIPAA compliance regulations for small and mid-sized medical practices.

TAMPA, FLORIDA, USA, December 5, 2016 /EINPresswire.com/ — Continual Compliance Solutions (CCS) today announces the launch of Abyde™ – a revolutionary software solution that changes the way medical practices manage internal HIPAA compliance programs. Abyde™ enables healthcare practices of all sizes to easily attain and sustain HIPAA compliance programs that meet Government regulations by walking end users through the Risk Assessment, ongoing compliance, policies and procedures, and HIPAA training. By taking an automated approach to HIPAA, Abyde™ delivers peace of mind to healthcare professionals that their organization is adhering to the 2016 HIPAA Audit Protocol set forth by the Department of Health and Human Services. In addition, Abyde™ addresses the Meaningful Use, MACRA, and MIPS Protecting Electronic Health Information core measure.

"We are excited to introduce an easy-to-use HIPAA compliance solution for independent physicians and their staff," said Matt DiBlasi, President of CCS. "The private practice has been completely underserved with HIPAA compliance solutions leaving hundreds of thousands of physicians exposed to devastating fines associated with a failed audit or even worse – a catastrophic data breach. We look forward to providing a user friendly experience that completely relieves the burden of staying current with HIPAA complexities, freeing doctors and staff to focus on patient care and increasing profitability."

About Continual Compliance Solutions:
CCS is a technology company comprised of HIPAA compliance experts that provides software solutions to the independent physician. CCS was formed with the idea that there could exist an easier, more cost-effective way for independent physicians to comply with government mandated HIPAA standards. This is accomplished through a user friendly software solution that navigates covered entities through all aspects of attaining and maintaining proper compliance programs. CCS's Abyde™ software is a healthcare industry game-changer and is considered the gold standard for HIPAA compliance solutions.

Matt DiBlasi
Continual Compliance Solutions
1(800)-594-0883
email us here

Continual Compliance Solutions – Who We Are


Source: EIN Presswire